Recent Scientific Publications

Acute and 30 Day Results of a Multi-Center Study on a Novel Apical Closure Device

Treede H, et al. ISMICS: International Society for Minimally Invasive Cardiothoracic Surgery. Acute 30 day results of a multi-center study on a novel apical closure device. June 2015

 

Objective: Transapical access for transcatheter aortic valve implantation (TA-TAVI) has become a routine procedure for patients at high surgical risk as an alternative to transfemoral access.

Acute 30 and 90 Day Results of the STASIS Trial: A multi-center study

Treede H, et al. TCT-688 Acute 30 and 90-day results of the STASIS trial: a multi-center study on a novel apical closure device for transapical aortic valve implantation. JACC. 2015; 66(15 Suppl B) B281. October 2015

 

Background:Transapical access for transcatheter aortic valve implantation (TA-TAVI) has become a routine procedure for patients at high surgical risk and is a valid alternative to transfemoral TAVI. Transapical access has seen little standardization of technique due to the absence of automated preclosure and carries a risk for bleeding complications.

Acute and 30 Day Results of the STASIS Trial a Multicentre Study for a Novel

Treede H, et al. EuroIntervention: Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Acute and 30-day results of the STASIS trial: a multicentre study on a novel apical closure device for transapical transcatheter aortic valve implantation. May 2015

 

Aims: Transapical access for transcatheter aortic valve implantation (TA-TAVI) has become a routine procedure for patients at high surgical risk and is a valid alternative to transfemoral TAVI. Transapical access has seen little standardisation of technique due to the absence of automated preclosure andcarries a risk for bleeding complications.

Micro Interventional Devices: Creating a Tool Box for Structural Heart Disease

In Vivo The Business and Medicine Report; Volume 30; No 6. Mary Stuart. June 2012. 

 

A decade of treating patients with transcatheter heart valves has produced opportunities for new and adjunct technologies. Micro Interventional Devices is looking to address these needs with a suite of products that support existing therapies and provide new ones.

 

5 Caufield Place, Suite 102, Newtown, PA 18940

215-600-1270 - info@microinterventional.com

     

     © 2016 by Micro Interventional Devices, Inc.